Citation: European Neuropsychopharmacology
The Journal of the European College of Neuropsychopharmacology
Volume 21 (2011), Supplement 3, Page S221( Tuesday, 06 September 2011)
T. Sharp1, H. Hartung1, S. Tan2, V. Visser-Vandewalle2, Y. Temel2
1University of Oxford, Department of Pharmacology, Oxford, United Kingdom
2University of Maastricht, Department of Neuroscience and Neurosurgery, Maastricht, The Netherlands
High-frequency stimulation (HFS) of the STN is an established surgical therapy of advanced Parkinson's disease (PD). However, despite beneficial motor effects this procedure often causes debilitating psychiatric side-effects, including depressed mood [1], and is associated with increased suicide risk [2]. Depression is linked to changes in 5-hydroxytryptamine (5-HT) and previously we reported that, in animal models, STN HFS inhibited the firing of putative 5-HT neurons in the dorsal raphe nucleus (DRN) of the midbrain [3]. Here we have further investigated this phenomenon using a combination of in vivo electrophysiological and neurochemical studies.
STN HFS caused a clear-cut inhibition (20–30%) in the majority of DRN neurons but a smaller proportion of neurons were either excited or non-responsive. Juxtacellular labelling studies demonstrated 5-HT-immunopositive neurons in each of these response categories. In microdialysis experiments STN HFS evoked a modest (25%) fall in extracellular 5-HT (prefrontal cortex and striatum) in both anaesthetised and awake animals. Previous anatomical studies demonstrate STN-DRN connections via the lateral habenula (LHb), which is increasingly implicated in the neural circuitry of depression. Interestingly, STN HFS increased c-fos expression in the LHb, and also increased neuronal firing in this nucleus.
These data demonstrate a powerful modulatory effect of STN HFS on 5-HT neurons but suggest destabilisation rather than simple inhibition. The data implicate the LHb in the neural circuitry mediating this effect. Altered function of STN-DRN neural connectivity may contribute to the adverse psychiatric effects of STN HFS in PD patients, and to mood disturbances in PD patients more generally.
References:
1. Temel Y., Kessels A., Tan S., Topdag A., Boon P., Visser-Vandewalle V., 2006, Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord. 12, 265–272.
2. Voon V., Krack P., Lang A.E. et al, 2008, A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131, 2720–2728.
3. Temel Y., Boothman L.J., Blokland A., Magill P.J., Steinbusch H.W., Visser-Vandewalle V., Sharp T., 2007, Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci 104, 17087–17092.
The Journal of the European College of Neuropsychopharmacology
Volume 21 (2011), Supplement 3, Page S221( Tuesday, 06 September 2011)
T. Sharp1, H. Hartung1, S. Tan2, V. Visser-Vandewalle2, Y. Temel2
1University of Oxford, Department of Pharmacology, Oxford, United Kingdom
2University of Maastricht, Department of Neuroscience and Neurosurgery, Maastricht, The Netherlands
High-frequency stimulation (HFS) of the STN is an established surgical therapy of advanced Parkinson's disease (PD). However, despite beneficial motor effects this procedure often causes debilitating psychiatric side-effects, including depressed mood [1], and is associated with increased suicide risk [2]. Depression is linked to changes in 5-hydroxytryptamine (5-HT) and previously we reported that, in animal models, STN HFS inhibited the firing of putative 5-HT neurons in the dorsal raphe nucleus (DRN) of the midbrain [3]. Here we have further investigated this phenomenon using a combination of in vivo electrophysiological and neurochemical studies.
STN HFS caused a clear-cut inhibition (20–30%) in the majority of DRN neurons but a smaller proportion of neurons were either excited or non-responsive. Juxtacellular labelling studies demonstrated 5-HT-immunopositive neurons in each of these response categories. In microdialysis experiments STN HFS evoked a modest (25%) fall in extracellular 5-HT (prefrontal cortex and striatum) in both anaesthetised and awake animals. Previous anatomical studies demonstrate STN-DRN connections via the lateral habenula (LHb), which is increasingly implicated in the neural circuitry of depression. Interestingly, STN HFS increased c-fos expression in the LHb, and also increased neuronal firing in this nucleus.
These data demonstrate a powerful modulatory effect of STN HFS on 5-HT neurons but suggest destabilisation rather than simple inhibition. The data implicate the LHb in the neural circuitry mediating this effect. Altered function of STN-DRN neural connectivity may contribute to the adverse psychiatric effects of STN HFS in PD patients, and to mood disturbances in PD patients more generally.
References:
1. Temel Y., Kessels A., Tan S., Topdag A., Boon P., Visser-Vandewalle V., 2006, Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord. 12, 265–272.
2. Voon V., Krack P., Lang A.E. et al, 2008, A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131, 2720–2728.
3. Temel Y., Boothman L.J., Blokland A., Magill P.J., Steinbusch H.W., Visser-Vandewalle V., Sharp T., 2007, Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci 104, 17087–17092.
Hier à 22:40 par reduc
» Neuro-ophtalmologie
Hier à 21:54 par aqw1997
» Urgences en neuro-ophtalmologie
Hier à 21:53 par aqw1997
» EMC -Techniques Chirurgicales 2020 7 en 1 livre (Tête & cou -Chirurgie plastique-Thorax -Appareil digestif -Gynécologie - urologie Chirurgie vasculaire édition sba-medecine 2020 (avec misa à jour 2020)
Hier à 21:33 par FERHATmomo
» LE LIVRE NOIR DES ALLERGIES #Allergologie
Hier à 08:45 par zebra1964
» Conférences d'enseignement 2018
Sam 23 Nov 2024, 22:14 par mohsif123
» Mise à jour EMC 2020 (AKOS (TRAITE DE MEDECINE) + APPAREIL LOCOMOTEUR + ANESTHESIE-REANIMATION) #Orthopédie #Réanimation
Sam 23 Nov 2024, 20:21 par Bhk
» EMC AKOS (Traité de Médecine) mise à jour III 2020 (20 juillet 2020) #AKOS
Sam 23 Nov 2024, 20:18 par Bhk
» emc Dermatologie I-2020
Sam 23 Nov 2024, 12:53 par pilote
» ATLAS d'Échographie
Sam 23 Nov 2024, 00:11 par Baaloudjo
» Pratique de l'échographie obstétricale au 1er trimestre
Ven 22 Nov 2024, 15:02 par toufikflt
» L'échographie pour tous : apprentissage acceléré - de l'échoscopie a l'échographie d'expert
Ven 22 Nov 2024, 14:55 par toufikflt
» les lasers en dermatologie 2018 - exclusif
Ven 22 Nov 2024, 14:00 par mohsif123
» LES OSTÉOTOMIES AUTOUR DU GENOU Cahiers d'Enseignement de la SOFCOT
Ven 22 Nov 2024, 13:54 par mohsif123
» Conférences d'enseignement de la SFOCOT 2019
Ven 22 Nov 2024, 13:52 par mohsif123